Saturday, December 20, 2014 11:33:21 AM
I think its all been said - real company, real products, efficacy, drug-free, the FDA working, as it stated, "on its own initiative", and, "based on new information", to reclassify and approve these devices in the USA and help to get 'em to market to curtail Rx drug addiction issues, save billions of dollars in treatment costs and misery for those hooked on chemical analgesics and save American lives and families for the worst cases. Can there be any greater mission or reasons for expediency for the FDA in completing this project?
Patience and a little of "The Best Yam Vodka On Earth" from Jim Eason, Master Distiller over at Covington Spirits, that's the recipe.
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM